BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 32741386)

  • 1. In-Hospital Delays for Acute Stroke Treatment Delivery During the COVID-19 Pandemic.
    Katsanos AH; de Sa Boasquevisque D; Al-Qarni MA; Shawawrah M; McNicoll-Whiteman R; Gould L; Van Adel B; Sahlas DJ; Ng KKH; Perera K; Sharma M; Oczkowski W; Pikula A; Shoamanesh A; Catanese L
    Can J Neurol Sci; 2021 Jan; 48(1):59-65. PubMed ID: 32741386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the COVID-19 Pandemic on Treatment Times for Acute Ischemic Stroke: The Society of Vascular and Interventional Neurology Multicenter Collaboration.
    Siegler JE; Zha AM; Czap AL; Ortega-Gutierrez S; Farooqui M; Liebeskind DS; Desai SM; Hassan AE; Starosciak AK; Linfante I; Rai V; Thon JM; Then R; Heslin ME; Thau L; Khandelwal P; Mohammaden MH; Haussen DC; Nogueira RG; Jillella DV; Nahab F; Kaliaev A; Nguyen TN; Zaidat O; Jovin TG; Jhadav AP
    Stroke; 2021 Jan; 52(1):40-47. PubMed ID: 33250041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Impact of the COVID-19 Pandemic on Acute Stroke Treatment Delays.
    Neves Briard J; Ducroux C; Jacquin G; Alesefir W; Boisseau W; Daneault N; Deschaintre Y; Eneling J; Gioia LC; Iancu D; Odier C; Raymond J; Roy D; Stapf C; Weill A; Poppe AY
    Can J Neurol Sci; 2021 Jan; 48(1):122-126. PubMed ID: 32698917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delays in Stroke Onset to Hospital Arrival Time During COVID-19.
    Teo KC; Leung WCY; Wong YK; Liu RKC; Chan AHY; Choi OMY; Kwok WM; Leung KK; Tse MY; Cheung RTF; Tsang AC; Lau KK
    Stroke; 2020 Jul; 51(7):2228-2231. PubMed ID: 32432998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous tPA Delays Door-To-Puncture Time in Acute Ischemic Stroke with Large Vessel Occlusion.
    Atchaneeyasakul K; Desai S; Malhotra K; Dolia J; Shah K; Saver JL; Jovin T; Jadhav AP
    J Stroke Cerebrovasc Dis; 2021 Jun; 30(6):105732. PubMed ID: 33865227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shortening Door-to-Needle Time by Multidisciplinary Collaboration and Workflow Optimization During the COVID-19 Pandemic.
    Chen Y; Nguyen TN; Wellington J; Mofatteh M; Yao W; Hu Z; Kuang Q; Wu W; Wang X; Sun Y; Ouyang K; Xu J; Huang W; Yang S
    J Stroke Cerebrovasc Dis; 2022 Jan; 31(1):106179. PubMed ID: 34735901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke Care in the First Affiliated Hospital of Chengdu Medical College during the COVID-19 Outbreak.
    Zhang LL; Guo YJ; Lin YP; Hu RZ; Yu JP; Yang J; Wang X
    Eur Neurol; 2020; 83(6):630-635. PubMed ID: 33341815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a code stroke protocol on the door-to-needle time for IV thrombolysis: a feasibility study.
    Vanhoucke J; Hemelsoet D; Achten E; De Herdt V; Acou M; Vereecke E; Hachimi-Idrissi S
    Acta Clin Belg; 2020 Aug; 75(4):267-274. PubMed ID: 31081471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of COVID-19 pandemic in stroke code activation and time from symptom onset to hospital arrival in a Portuguese comprehensive stroke centre.
    Rodrigues M; Grunho M; Rachão A; Silva E; Cordeiro A; Guilherme M; Pereira L
    Rev Neurol; 2021 Aug; 73(3):89-95. PubMed ID: 34291445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Network-Wide Stroke Team Program Reduces Time to Treatment for Endovascular Stroke Therapy in a Regional Stroke-Network.
    Bohmann FO; Tahtali D; Kurka N; Wagner M; You SJ; du Mesnil de Rochemont R; Berkefeld J; Hartmetz AK; Kuhlmann A; Lorenz MW; Schütz A; Kress B; Henke C; Tritt S; Meyding-Lamadé U; Steinmetz H; Pfeilschifter W
    Cerebrovasc Dis; 2018; 45(3-4):141-148. PubMed ID: 29587257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular Thrombectomy Alone versus Combined with Intravenous Thrombolysis.
    Phan K; Dmytriw AA; Maingard J; Asadi H; Griessenauer CJ; Ng W; Kewagamang K; Mobbs RJ; Moore JM; Ogilvy CS; Thomas AJ
    World Neurosurg; 2017 Dec; 108():850-858.e2. PubMed ID: 28823660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of COVID-19 outbreak in reperfusion therapies of acute ischaemic stroke in northwest Spain.
    Tejada Meza H; Lambea Gil Á; Sancho Saldaña A; Martínez-Zabaleta M; Garmendia Lopetegui E; López-Cancio Martínez E; Castañón Apilánez M; Herrera Isasi M; Marta Enguita J; Gómez-Vicente B; Arenillas JF; Arenaza Basterrechea N; Timiraos Fernández JJ; Sánchez Herrero J; Maciñeiras Montero JL; Castellanos Rodrigo M; Fernández-Coud D; Casado Menéndez I; Temprano Fernández MT; Freijo M; Luna A; Palacio Portilla EJ; Jiménez López Y; Rodríguez-Castro E; Rodríguez-Yáñez M; Tejada García J; Beltrán Rodríguez I; Julián-Villaverde F; Moreno García MP; Trejo Gabriel-Galán JM; Echavarría Iñiguez A; Pérez Lázaro C; Navarro Pérez MP; Marta Moreno J;
    Eur J Neurol; 2020 Dec; 27(12):2491-2498. PubMed ID: 32761981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Feasibility of Argatroban, Recombinant Tissue Plasminogen Activator, and Intra-Arterial Therapy in Stroke (ARTSS-IA Study).
    Berekashvili K; Soomro J; Shen L; Misra V; Chen PR; Blackburn S; Dannenbaum M; Grotta JC; Barreto AD
    J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3647-3651. PubMed ID: 30249518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of endovascular thrombectomy with and without bridging thrombolysis for acute large vessel occlusion ischaemic stroke.
    Maingard J; Shvarts Y; Motyer R; Thijs V; Brennan P; O'Hare A; Looby S; Thornton J; Hirsch JA; Barras CD; Chandra RV; Brooks M; Asadi H; Kok HK
    Intern Med J; 2019 Mar; 49(3):345-351. PubMed ID: 30091271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthy Life-Year Costs of Treatment Speed From Arrival to Endovascular Thrombectomy in Patients With Ischemic Stroke: A Meta-analysis of Individual Patient Data From 7 Randomized Clinical Trials.
    Almekhlafi MA; Goyal M; Dippel DWJ; Majoie CBLM; Campbell BCV; Muir KW; Demchuk AM; Bracard S; Guillemin F; Jovin TG; Mitchell P; White P; Hill MD; Brown S; Saver JL;
    JAMA Neurol; 2021 Jun; 78(6):709-717. PubMed ID: 33938914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endovascular Treatment in Patients with Persistent Internal Carotid Artery Occlusion after Intravenous Tissue Plasminogen Activator: A Clinical Effectiveness Study.
    Hong JH; Sohn SI; Kang J; Jang MU; Kim BJ; Han MK; Park TH; Park SS; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Cho KH; Kim JT; Choi JC; Lee J; Lee JS; Gorelick PB; Bae HJ
    Cerebrovasc Dis; 2016; 42(5-6):387-394. PubMed ID: 27359223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time from I.V. Thrombolysis to Thrombectomy and Outcome in Acute Ischemic Stroke.
    Zhu F; Gauberti M; Marnat G; Bourcier R; Kyheng M; Labreuche J; Sibon I; Dargazanli C; Arquizan C; Anxionnat R; Audibert G; Mazighi M; Blanc R; Lapergue B; Consoli A; Richard S; Gory B;
    Ann Neurol; 2021 Mar; 89(3):511-519. PubMed ID: 33274475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Reperfusion Therapy for In-Hospital Ischemic Stroke in the Endovascular Therapy Era.
    Akbik F; Xu H; Xian Y; Shah S; Smith EE; Bhatt DL; Matsouaka RA; Fonarow GC; Schwamm LH
    JAMA Neurol; 2020 Dec; 77(12):1486-1495. PubMed ID: 32955582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 24/7 Neurocritical Care Nurse Practitioner Coverage Reduced Door-to-Needle Time in Stroke Patients Treated with Tissue Plasminogen Activator.
    Moran JL; Nakagawa K; Asai SM; Koenig MA
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1148-1152. PubMed ID: 26907680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endovascular stroke treatment does not preclude high thrombolysis rates.
    Feda S; Nikoubashman O; Schürmann K; Matz O; Tauber SC; Wiesmann M; Schulz JB; Reich A
    Eur J Neurol; 2019 Mar; 26(3):428-e33. PubMed ID: 30317687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.